Quick Answer
SpyGlass Pharma, Inc. reported Diluted EPS of $17.98 per share (loss) for fiscal year 2025.
SpyGlass Pharma, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$17.98 | -10.2% |
| 2024 | -$16.31 | — |
- SpyGlass Pharma, Inc. showed a decrease of -10.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2024–2025 period, SpyGlass Pharma, Inc.’s diluted eps has declined by 10.2% (from $16.31 per share (loss) to $17.98 per share (loss)).
- The most recent figure is from SpyGlass Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: